Over the past few days, medtech's biggest names gathered in San Francisco for the Transcatheter Cardiovascular Therapies (TCT ...

Brainomix, a global leader and pioneer of AI-powered imaging tools in stroke and lung fibrosis, has been named a winner in ...

Despite major advances in care, nearly half of U.S. adults live with some form of cardiovascular disease or stroke, according to the American Heart Association(R), a relentless force changing the ...

Emerging cardiovascular technology, trends in ambulatory care, provider and payer partnerships, and value-based arrangements create strategic opportunities to address service demand and cost pressures ...

The American College of Cardiology has partnered with OpenEvidence to speed up the translation of research into clinical implementation.  Through the strategic partnership, OpenEvidence users will ...

Despite making up half of the 64 million people living with heart failure, patients with this common form have no access to ...

Please provide your email address to receive an email when new articles are posted on . The European and UK markets will have access to the CLAiR technology from Toku. CLAiR assesses cardiovascular ...

The hospital has continued to see growth in scans at multiple locations – meaning it is holistically seeing more patients who ...

Here, five cardiology leaders weigh in on the possibilities of ending cardiovascular disease: Gopi Dandamudi, MD. Executive Medical Director of the Center for Cardiovascular Health at Virginia Mason ...

Modern cardiovascular care involves human acumen, complex data and collaborative intelligence between the two. Payment models are based on well-defined tests and procedures and are baffled by the ...

Novo Nordisk’s oral therapy Wegovy (semaglutide) reduced cardiovascular risk factors in the Phase III OASIS 4 trial. Being ...